Product How it works Pricing Blog FAQ About Contact
Ginkgo Bioworks

Ginkgo Bioworks (NYSE: DNA) revenue

Ginkgo Bioworks reported revenue of $170.2m for fiscal 2025, 25.1% less than in fiscal 2024 ($227.0m). Since fiscal 2020 its revenue has grown by 122.0%, an average growth of 17.3% a year.

Ginkgo Bioworks's revenue has fallen for 3 years in a row, and its best year of the last 6 was fiscal 2022. The biggest drop was in fiscal 2023, −47.4%.

Revenue, in millions of US dollars76.72020313.82021477.72022251.52023227.02024170.22025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$170.2m−25.1%−$315.3m−185.3%
2024$227.0m−9.7%−$559.8m−246.5%
2023$251.5m−47.4%−$864.4m−343.8%
2022$477.7m+52.2%−$2,209m−462.4%
2021$313.8m+309.4%−$1,828m−582.6%
2020$76.7m—−$137.0m−178.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Ginkgo Bioworks revenue compared with its sector

By revenue for its latest fiscal year, Ginkgo Bioworks ranks 258th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ginkgo Bioworks, −25.1%.

RankCompanyRevenueRevenue growth
256thSyndax Pharmaceuticals$172.4m627.8%
257thRegenxbio$170.4m104.5%
258thGinkgo Bioworks$170.2m−25.1%
259thPacific Biosciences of California$160.0m3.9%
260thLiquidia$158.3m1,031.2%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Ginkgo Bioworks

How much revenue did Ginkgo Bioworks make in fiscal 2025?
Ginkgo Bioworks reported revenue of $170.2m for fiscal 2025, compared with $227.0m in fiscal 2024.
How much has the revenue of Ginkgo Bioworks grown?
Between fiscal 2020 and fiscal 2025 it went from $76.7m to $170.2m: 122.0% more, an average growth of 17.3% a year.
What was the best year for revenue at Ginkgo Bioworks?
Of its last 6 fiscal years, fiscal 2022, with $477.7m.
Where does Ginkgo Bioworks rank in its sector by revenue?
It ranks 258th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Ginkgo Bioworks come from?
From the annual report (Form 10-K) that Ginkgo Bioworks files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Ginkgo Bioworks files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Ginkgo Bioworks: the Ginkgo Bioworks page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.